Letters to the editor

Spiller JA , Keen JC. Hypoactive delirium: assessing the extent of the problem for inpatient specialist palliative care. Palliat Med 2006; 20: 17-23.

Jennett B. Development of Glasgow Coma and Outcome Scale. Nepal J Neurosci 2005; 2: 24-28.

English Consent Law FAQ. Department of Health. Retrieved from http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/Consent/ConsentFAQ/fs/en?CONTENT_ID-/4039322&chk-/oDHcDp%235100307

Consent - what you have a right to expect. Department of Health. Retrieved from http://www.dh.gov.uk/assetRoot/04/06/69/93/04066993.pdf

Governance arrangements for NHS Research Ethics Committees, published by the Department of Health in 2001: 7. Retrieved from http://www.dh.gov.uk/assetRoot/04/05/86/09/04058609.pdf

Research Governance Framework for Health and Social Care, second edition. Department of Health, 2005: 7-7. Retrieved from http://www.dh.gov.uk/assetRoot/04/12/24/27/04122427.pdf

Scottish Executive. Adults with Incapacity (Scotland) Act, 2000.

Adamis D , Martin FC , Treloar A , Macdonald AJD. Capacity, consent, and selection bias in a study of delirium. J Med Ethics 2005; 31: 137-143.

World Medical Association Declaration of Helsinki . Ethical principles for medical research involving human subjects. As amended by the 52nd WMA General Assembly, Edinburgh, October 2000.

Spiller JA , Keen JC. Hypoactive delirium; assessing the extent of the problem for inpatient specialist palliative care. Palliat Med 2006; 20: 17-23.

Jennet B. Development of Glasgow Coma and Outcome Scale. Nepal J Neurosci 2005; 2: 24-28.

Guldenpfennig WM , Poole KH , Sommerville KW , Boroojerdi B. Safety, tolerability, and efficacy of continuous transdermal dopaminergic stimulation with rotigotine patch in early stage idiopathic Parkinson disease. Clin Neuropharmacol 2005; 28(3): 106-110.

Rascol O. Transdermal delivery of dopaminergic agents. Neurology 2005 (Supplement); 65(2): 1-2.

Schwarz Pharma. Summary of product characteristics, Rotigotine Transdermal Patch (Neupro), 2006.

Reynolds NA , Wellington K , Easthope SE. Rotigotine: in Parkinson’s disease. CNS Drugs 2005; 19(11): 973-981.

Poewe W , Luessi F. Clinical studies with transdermal rotigotine in early Parkinson’s disease. Neurology 2005 (Supplement); 65(2): 11-14.

Metman LV , Gillespie M , Farmer C , et al. Continuous transdermal dopaminergic stimulation in advanced PD. Clin Neuropharmacol 2001; 24(3): 163-169.

Witjas T , Kaphan E , Azulay JP. Non-motor fluctuations in Parkinson’s disease: frequent and disabling. Neurology 2002; 59(3): 408-413.